Rotate injection sites weekly to prevent lipodystrophy, a condition where repeated injections in the same spot cause tissue changes that affect absorption
Lanz S, Maihfner C
In recent years, significant advances have been made in the pharmaceutical field for treating obesity, particularly through Novo Nordisks development of the GLP-1 receptor agonist semaglutide , which has had a major impact and revolutionized treatment
Most Common Side Effects Can Include: Abdominal pain, increase in heart rate, diarrhea, vomiting, constipation, nausea, headache, fatigue, dyspepsia, dizziness, abdominal distension, eructation, retinal disorder (diabetes mellitus patients), hypoglycemia (diabetes mellitus patients), flatulence, gastroenteritis, lipase increase, gastritis, alopecia, GERD, amylase increase, injection site reaction, hypotension
An effect of L-leucine and other essential amino acids on the structure and activity of glutamic dehydrogenase
L.CoelhoC